SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950135-08-004053
Filing Date
2008-05-28
Accepted
2008-05-28 17:23:38
Documents
3
Period of Report
2008-05-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 EPIX PHARMACEUTICALS, INC. b70289epe8vk.htm 8-K 13266
2 EX-99.1 PRESS RELEASE ISSUED BY THE REGISTRANT ON MAY 28, 2008 b70289epexv99w1.htm EX-99.1 4921
3 GRAPHIC b70289epb7028901.gif GRAPHIC 4042
  Complete submission text file 0000950135-08-004053.txt   25568
Mailing Address 4 MAGUIRE ROAD LEXINGTON MA 02421
Business Address 4 MAGUIRE ROAD LEXINGTON MA 02421 6172506000
EPIX Pharmaceuticals, Inc. (Filer) CIK: 0001027702 (see all company filings)

IRS No.: 043030815 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21863 | Film No.: 08864346
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1